Mechanism of microthrombosis in HUS.
The mechanism of formation of the microthrombi in hemolytic uremic syndrome (HUS) is not known. Plasma from five adult and six pediatric cases of HUS showed aggregation and release of adenosine triphosphate from normal platelets. When the plasma was absorbed with staphylococcal protein A and again exposed to normal platelets there was no aggregation or release, indicating that an antibody was responsible for the aggregation. The plasma reacted with platelet lysate in a western blot, showing reactivity with CD36. This was confirmed by probing with Mo91, a monoclonal antibody to CD36. When the patient's plasma was used to probe purified verotoxin-2, bands of 32 and 7.7 kDa were obtained. Similar results were obtained using Mo91. The reactions suggest structural homologies between CD36 and verotoxin. Although a direct cause-effect relationship is not yet established, the data support the concept of an immunological pathogenesis for HUS with the formation of cross-reacting antibodies.
Rock
Gail A
GA
Canadian Apheresis Group, Ottawa, Ontario, Canada. cag@ca.inter.net
Clark
William F
WF
D000255:Adenosine Triphosphate / Q000097:blood; D000328:Adult; D000918:Antibody Specificity; D001323:Autoantibodies / Q000097:blood*; D001792:Blood Platelets / Q000276:immunology* / Q000378:metabolism; D018955:CD36 Antigens / Q000276:immunology*; D002648:Child; D003429:Cross Reactions; D006463:Hemolytic-Uremic Syndrome / Q000097:blood / Q000276:immunology*; D006801:Humans; D055806:Microvessels / Q000276:immunology*; D018716:Molecular Mimicry; D010974:Platelet Aggregation; D022641:Shiga Toxin 2 / Q000276:immunology*; D013927:Thrombosis / Q000097:blood / Q000276:immunology*
D001323:Autoantibodies; D018955:CD36 Antigens; D022641:Shiga Toxin 2; D000255:Adenosine Triphosphate